Russia’s $27 Billion Bet on Beating Aging—Hype or Hope?

With an ambitious goal of conquering aging, Russia is investing $26 to $28 billion in a national health initiative.

(Russian leader, Vladimir Putin | RBC-Ukraine)

Aging &amp; Longevity

The Rise of China’s Longevity Movement: A Quest to Defy Aging

China’s national project to crush aging encompasses longevity labs, “immortality islands,” and grapeseed pills, as well as exorbitant claims based on sometimes questionable science.

(Attendees at a conference in Shanghai try out a cryogenic chamber in which temperatures plummeted to approximately -200 degrees Fahrenheit, meant to slow aging | New York Times)

A surge in the Chinese public’s interest in longevity science has led to substantial investments from the state and private companies in aging research.

Columbia University scientists find that inflammation increases the risk of common chronic age-related diseases only in people from industrialized populations. 

Columbia University in New York City (image: Columbia.edu). 

Immunity

Biotech Startup Aims to Harness New NAD+-Related Drug Against Aging

The longevity biotech company, MetaShape, has a new compound designed to restore cellular nicotinamide adenine dinucleotide (NAD+) and offset elevated cholesterol, cognitive decline, and neurodegeneration.

Assuming the science works, the cost of cryogenics and the typical lifecycles of companies make the prospect of suspended animation as a business a bit tricky.


Search Result: Russia

Russia’s $27 Billion Bet on Beating Aging—Hype or Hope?

The Rise of China’s Longevity Movement: A Quest to Defy Aging

The Inflammation Myth: New Insights on Aging

Biotech Startup Aims to Harness New NAD+-Related Drug Against Aging

Humans Are Freezing Themselves in Hopes of Being Revived in the Future, but Is It Worth It?